A Silver Lining in the VAD Sky (LVAD-SilverD)
LVAD (Left Ventricular Assist Device) Driveline Infection
About this trial
This is an interventional prevention trial for LVAD (Left Ventricular Assist Device) Driveline Infection
Eligibility Criteria
Inclusion Criteria:
- >18 years of age
- Implanted with LVAD as DT or BTT at the Academic Medical Center with implantation scheduled between January 1st, 2022 and December 31st, 2022
Exclusion Criteria:
- A history of DLI
- A history of sternal wound infection
- Implantation secondary to VAD exchange for device infection
Sites / Locations
- UCSF ParnassusRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
SilverD
ControlD
The SIlverD arm includes: For standard dressing: a silverlon antimicrobial patch, CHG swabs for cleaning, an occlusive dressing with window, and driveline anchors. The driveline dressing change frequency will be weekly. For sensitive skin dressing: a silverlon antimicrobial patch, Providone/iodine swabs for cleaning, an occlusive dressing with window, and sensitive driveline anchors. The driveline dressing change frequency will be weekly.
The ControlD arm includes: For standard dressing: No antimicrobial barrier, CHG swabs for cleaning, an occlusive dressing with window, and driveline anchors. The driveline dressing change frequency will be every 96 hours. For sensitive skin dressing: No antimicrobial barrier, Providone/iodine swabs for cleaning, an occlusive dressing with window, and driveline anchors. The driveline dressing change frequency will be every 96hr.